FDA Drug Application (204435) for NEOMYCIN SULFATE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number204435
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameNEOMYCIN SULFATE
Active IngredientNEOMYCIN SULFATE

Active IngredientCount
List of drugs with Active Ingredient NEOMYCIN SULFATE49


Back to FDA Applications sponsored by LANNETT HOLDINGS INC